BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21623776)

  • 1. The effect of oral isotretinoin (13-cis retinoic acid) on hearing systems in patients with acne vulgaris: a prospective study.
    Karabulut H; Karadag AS; Acar B; Dagli M; Karabulut I; Ozmen E; Babademez MA; Karaşen RM
    Int J Dermatol; 2011 Sep; 50(9):1139-43. PubMed ID: 21623776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study.
    Lee JW; Yoo KH; Park KY; Han TY; Li K; Seo SJ; Hong CK
    Br J Dermatol; 2011 Jun; 164(6):1369-75. PubMed ID: 21114478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of isotretinoin on social anxiety and quality of life in patients with acne vulgaris: a prospective trial.
    Yesilova Y; Bez Y; Ari M; Turan E
    Acta Dermatovenerol Croat; 2012; 20(2):80-3. PubMed ID: 22726279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermabrasion for acne scars during treatment with oral isotretinoin.
    Bagatin E; dos Santos Guadanhim LR; Yarak S; Kamamoto CS; de Almeida FA
    Dermatol Surg; 2010 Apr; 36(4):483-9. PubMed ID: 20180836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents.
    Kaymak Y; Taner E; Taner Y
    Int J Dermatol; 2009 Jan; 48(1):41-6. PubMed ID: 19126049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of oral isotretinoin effects on hearing system in patients with acne vulgaris: Reversible or not?
    Kemeriz F; Kayabaşı S; Cevirgen Cemil B; Hızlı Ö
    Dermatol Ther; 2021 Jan; 34(1):e14640. PubMed ID: 33278063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific gel-cream as adjuvant to oral isotretinoin improved hydration and prevented TEWL increase--a double-blind, randomized, placebo-controlled study.
    Herane MI; Fuenzalida H; Zegpi E; De Pablo C; Espadas MJ; Trullás C; Mirada A; Martin GG
    J Cosmet Dermatol; 2009 Sep; 8(3):181-5. PubMed ID: 19735515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotretinoin treatment induces oxidative toxicity in blood of patients with acne vulgaris: a clinical pilot study.
    Erturan İ; Naziroğlu M; Akkaya VB
    Cell Biochem Funct; 2012 Oct; 30(7):552-7. PubMed ID: 22517509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations.
    Dréno B; Bettoli V; Ochsendorf F; Perez-Lopez M; Mobacken H; Degreef H; Layton A
    Eur J Dermatol; 2006; 16(5):565-71. PubMed ID: 17101480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of isotretinoin on nasal mucociliary clearance and lung function in patients with acne vulgaris.
    Gorpelioglu C; Ozol D; Sarifakioglu E
    Int J Dermatol; 2010 Jan; 49(1):87-90. PubMed ID: 20465621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial.
    Agarwal US; Besarwal RK; Bhola K
    Indian J Dermatol Venereol Leprol; 2011; 77(6):688-94. PubMed ID: 22016276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose isotretinoin in the treatment of acne vulgaris.
    Amichai B; Shemer A; Grunwald MH
    J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acne: systemic treatment.
    Katsambas A; Papakonstantinou A
    Clin Dermatol; 2004; 22(5):412-8. PubMed ID: 15556728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of oral isotretinoin (13-Cis retinoic acid) on the inner ear: a prospective clinical study.
    Akdag M; Akkurt ZM; Gul A; Ucmak D; Yılmaz B; Sengul E; Topcu I
    Clin Invest Med; 2014 Apr; 37(2):E102-7. PubMed ID: 24690417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study.
    Akman A; Durusoy C; Senturk M; Koc CK; Soyturk D; Alpsoy E
    Arch Dermatol Res; 2007 Dec; 299(10):467-73. PubMed ID: 17710426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.